Bloomberg Reports on the WARF hESC Patent Challenge
The California-based challenge to the WARF patents involving hESC research drew national media coverage this week on Bloomberg News.
Susan Decker of Bloomberg described the heart of the matter as a dispute over who profits from stem cell research. She wrote,
“'What we’re asking the government to do is say WARF has no right' to the patent, said Dan Ravicher
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.